Table 1.
Cellular blood parameters; data are means ± SD; MCV = mean corpuscular volume; HBR = hypoxic bed rest (n = 14); NBR = normoxic bed rest (n = 13); HAMB = hypoxic ambulation (n = 12); BDC = Baseline Data Collection; R2 = 2 days after the end of condition; #Significant difference between HBR and NBR; +Significant difference between HAMB and HBR; *Significant difference between HAMB and NBR at the respective time points; µSignificant difference vs. BDC in the respective group (p < 0.05).
| Time points | HBR | NBR | HAMB | |
|---|---|---|---|---|
| Hemoglobin (g/dl) | BDC | 14.63 ± 0.75 | 14.60 ± 0.91 | 14.67 ± 0.56 |
| 2 | µ15.84 ± 0.95 | µ15.83 ± 1.03 | µ15.65 ± 0.59 | |
| 5 | µ16.54 ± 1.06 | µ15.80 ± 1.03 | µ15.69 ± 0.83 | |
| 14#,+ | µ17.50 ± 1.03 | µ16.05 ± 1.13 | µ16.12 ± 0.57 | |
| 21# | µ17.09 ± 1.13 | µ15.72 ± 1.26 | µ16.42 ± 0.83 | |
| R2 | 15.33 ± 1.15 | 15.37 ± 2.04 | 15.05 ± 0.92 | |
| Hematocrit (%) | BDC | 43.93 ± 2.12 | 44.15 ± 2.62 | 43.86 ± 2.21 |
| 2 | µ47.31 ± 2.55 | µ47.92 ± 2.95 | µ47.10 ± 1.72 | |
| 5 | µ49.63 ± 2.97 | µ47.49 ± 2.71 | µ47.18 ± 3.09 | |
| 14#,+ | µ51.11 ± 2.84 | µ47.41 ± 3.21 | µ48.09 ± 2.40 | |
| 21# | µ50.58 ± 3.31 | 46.42 ± 3.38 | µ48.90 ± 2.96 | |
| R2 | 44.91 ± 3.71 | 45.47 ± 6.31 | 44.98 ± 3.18 | |
| MCV (fl) | BDC | 84.64 ± 4.66 | 85.99 ± 4.68 | 87.89 ± 3.48 |
| 2 | 84.44 ± 5.10 | 85.99 ± 4.52 | 87.45 ± 3.50 | |
| 5 | 84.06 ± 4.62 | 85.39 ± 4.55 | 87.80 ± 3.36 | |
| 14+ | µ82.36 ± 5.11 | µ84.62 ± 3.84 | 87.31 ± 4.38 | |
| 21 | 83.51 ± 5.34 | µ84.13 ± 3.81 | 87.40 ± 4.86 | |
| R2 | 83.63 ± 4.97 | µ84.11 ± 4.20 | 88.17 ± 4.65 | |
| Thrombocytes (G/l) | BDC | 206.14 ± 76.65 | 197.92 ± 45.50 | 201.00 ± 42.36 |
| 2 | 233.86 ± 68.12 | 204.77 ± 49.37 | 229.83 ± 49.13 | |
| 5 | µ245.21 ± 51.08 | 215.08 ± 64.21 | 215.08 ± 56.22 | |
| 14 | µ260.29 ± 66.18 | 221.08 ± 75.07 | µ238.17 ± 40.30 | |
| 21 | µ237.36 ± 82.19 | 200.00 ± 69.38 | 212.92 ± 46.74 | |
| R2 | 210.14 ± 80.03 | 171.39 ± 73.27 | 196.58 ± 36.86 |